X-ray systems maker Varex's Q4 revenue beats expectations

Varex Imaging

18/11/2025 21:15

Overview

Varex Q4 revenue grows 11% yr/yr, beating analyst expectations

Non-GAAP EPS for Q4 rises to $0.37 from $0.19 last year

Company's revenue growth driven by Medical and Industrial segments

Outlook

Company expects Q1FY26 revenue between $200 mln and $215 mln

Company anticipates Q1FY26 non-GAAP EPS between $0.05 and $0.25

Result Drivers

MEDICAL SEGMENT - Global CT tube sales drove a 5% increase in Medical segment revenue

INDUSTRIAL SEGMENT - Sustained momentum in cargo systems business led to 25% growth in Industrial segment

GROWTH INITIATIVES - Co advanced photon counting technology for CT and launched radiographic detector from new facility in India

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$229 mln
$219.26 mln (5 Analysts)
Q4 Net Income
$12.20 mln
Q4 Gross Margin
34.00%
Q4 Adjusted Operating Margin
10.00%
Q4 Operating Income
$19.60 mln
Q4 Pretax Profit
$14.10 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Varex Imaging Corp is $16.00, about 28.6% above its November 17 closing price of $11.43

The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nBw1lcwrWa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)